Safety study of an inhaled drug in healthy adults
Part of Lungs & breathing clinical trials.
This trial tests the safety of a new inhaled medicine. You must be a healthy nonsmoker, have normal lung function, and agree to avoid certain medications and foods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy volunteer aged 18 to 60.
- Your weight must be at least 110 pounds (men) or 99 pounds (women), with a body mass index between 18 and 30.
- You must have normal lung function, including a forced exhale in 1 second (FEV1) of at least 80% of predicted.
- You cannot smoke, vape, or use nicotine products for 3 months before the study.
- You must avoid grapefruit, pomelo, alcohol, and caffeine for 48 hours before and during the study.
- You cannot have any serious medical conditions like heart disease, seizures, or bleeding disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called SV001 in healthy volunteers to see if it is safe and how the body handles it. It is a first-in-human trial, meaning this drug has not been tested in people before.
This trial tests an inhaled form of nintedanib (a drug that helps slow lung scarring) for people with idiopathic pulmonary fibrosis (IPF). It may be an option for those newly diagnosed or already on stable treatment.
This study tests whether a new tablet called SYH2059 can help slow lung scarring in adults with idiopathic pulmonary fibrosis (IPF), a condition where lung tissue becomes thick and stiff over time. You'll take the study drug alongside your current lung treatment to see if it improves your breathing and lung function.
This trial tests an oral medicine called rentosertib for people with idiopathic pulmonary fibrosis (IPF), a lung condition that causes scarring. It aims to see if the drug can help slow the disease. You may qualify if you are 40 or older, have a confirmed IPF diagnosis with certain lung function levels, and are either on a stable dose of standard IPF meds or not taking them.
This trial is testing a new drug called SCB0020160 in healthy adult men to see how safe it is and how the body processes it. You take the drug by mouth once or several times.
This trial tests a new inhaled medication called ICF004 in healthy Chinese adults to see if it is safe and how the body processes it. You can join if you are generally healthy and between 18 and 50 years old.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.